SAMANTHA WIDEMAN: Open Payments
NPI 1952052243 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,185 in 169 payments from 40 companies in 2025. Trend: 2023 $3,126 · 2024 $4,932 · 2025 $3,185
Food & beverage: $3,085Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 26 | $307 |
| AstraZeneca Pharmaceuticals LP | 11 | $299 |
| Incyte Corporation | 7 | $234 |
| PFIZER INC. | 12 | $210 |
| Exelixis Inc. | 9 | $176 |
| Daiichi Sankyo Inc. | 8 | $175 |
| Janssen Biotech, Inc. | 8 | $162 |
| GlaxoSmithKline, LLC. | 9 | $157 |
| Celgene Corporation | 12 | $143 |
| Eisai Inc. | 6 | $110 |
Products named: Enhertu, CABOMETYX, IMFINZI, JAKAFI, Lenvima, IBRANCE, Fabhalta, REBLOZYL.
Industry payments across AR — which companies pay providers there.
